A Purinergic Trail for Metastases

被引:25
作者
Ferrari, Davide [1 ]
Malavasi, Fabio [2 ,3 ,4 ]
Antonioli, Luca [5 ]
机构
[1] Univ Ferrara, Dept Life Sci & Biotechnol, Ferrara, Italy
[2] Univ Turin, Immunogenet Lab, Turin, Italy
[3] Univ Turin, CeRMS, Dept Med Sci, Turin, Italy
[4] Transplant Immunol Citta Salute & Sci, Turin, Italy
[5] Univ Pisa, Dept Clin & Expt Med, Pisa, Italy
关键词
ADENOSINE-TRIPHOSPHATE ATP; P2X(7) RECEPTOR EXPRESSION; TUMOR-CELL INVASION; BREAST-CANCER CELLS; CARCINOMA-CELLS; EXTRACELLULAR NUCLEOTIDES; CHEMOKINE PRODUCTION; ENDOTHELIAL-CELLS; PROSTATE-CANCER; ACTIVATION;
D O I
10.1016/j.tips.2016.11.010
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Nucleotides and nucleosides have emerged as important modulators of tumor biology. Recently acquired evidence shows that, when these molecules are released by cancer cells or surrounding tissues, they act as potent prometastatic factors, favoring tumor cell migration and tissue colonization. Therefore, nucleotides and nucleosides should be considered as a new class of prometastatic factors. In this review, we focus on the prometastatic roles of nucleotides and discuss future applications of purinergic signaling modulation in view of antimetastatic therapies.
引用
收藏
页码:277 / 290
页数:14
相关论文
共 117 条
  • [1] Nanotherapy silencing the interleukin-8 gene produces regression of prostate cancer by inhibition of angiogenesis
    Aalinkeel, Ravikumar
    Nair, Bindukumar
    Chen, Chih-Kuang
    Mahajan, Supriya D.
    Reynolds, Jessica L.
    Zhang, Hanguang
    Sun, Haotian
    Sykes, Donald E.
    Chadha, Kailash C.
    Turowski, Steven G.
    Bothwell, Katelyn D.
    Seshadri, Mukund
    Cheng, Chong
    Schwartz, Stanley A.
    [J]. IMMUNOLOGY, 2016, 148 (04) : 387 - 406
  • [2] P2X7 receptor expression in evolutive and indolent forms of chronic B lymphocytic leukemia
    Adinolfi, E
    Melchiorni, L
    Falzoni, S
    Chiozzi, P
    Morelli, A
    Tieghi, A
    Cuneo, A
    Castoldi, G
    Di Virgilio, F
    Baricordi, OR
    [J]. BLOOD, 2002, 99 (02) : 706 - 708
  • [3] [Anonymous], ONCOGENE
  • [4] Anti-CD73 immunotherapy: A viable way to reprogram the tumor microenvironment
    Antonioli, Luca
    Blandizzi, Corrado
    Malavasi, Fabio
    Ferrari, Davide
    Hasko, Gyoergy
    [J]. ONCOIMMUNOLOGY, 2016, 5 (09):
  • [5] Immunity, inflammation and cancer: a leading role for adenosine
    Antonioli, Luca
    Blandizzi, Corrado
    Pacher, Pal
    Hasko, Gyoergy
    [J]. NATURE REVIEWS CANCER, 2013, 13 (12) : 842 - 857
  • [6] CD39 and CD73 in immunity and inflammation
    Antonioli, Luca
    Pacher, Pal
    Vizi, E. Sylvester
    Hasko, Gyoergy
    [J]. TRENDS IN MOLECULAR MEDICINE, 2013, 19 (06) : 355 - 367
  • [7] Regulation of enteric functions by adenosine: Pathophysiological and pharmacological implications
    Antonioli, Luca
    Fornai, Matteo
    Colucci, Rocchina
    Ghisu, Narcisa
    Tuccori, Marco
    Del Tacca, Mario
    Blandizzi, Corrado
    [J]. PHARMACOLOGY & THERAPEUTICS, 2008, 120 (03) : 233 - 253
  • [8] Activation of P2X7 and P2Y11 purinergic receptors inhibits migration and normalizes tumor-derived endothelial cells via cAMP signaling
    Avanzato, D.
    Genova, T.
    Pla, A. Fiorio
    Bernardini, M.
    Bianco, S.
    Bussolati, B.
    Mancardi, D.
    Giraudo, E.
    Maione, F.
    Cassoni, P.
    Castellano, I.
    Munaron, L.
    [J]. SCIENTIFIC REPORTS, 2016, 6
  • [9] Tumor Cell Death and ATP Release Prime Dendritic Cells and Efficient Anticancer Immunity
    Aymeric, Laetitia
    Apetoh, Lionel
    Ghiringhelli, Francois
    Tesniere, Antoine
    Martins, Isabelle
    Kroemer, Guido
    Smyth, Mark J.
    Zitvogel, Laurence
    [J]. CANCER RESEARCH, 2010, 70 (03) : 855 - 858
  • [10] The P2Y2 nucleotide receptor interacts with αv integrins to activate Go and induce cell migration
    Bagchi, S
    Liao, ZJ
    Gonzalez, FA
    Chorna, NE
    Seye, CI
    Weisman, GA
    Erb, L
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2005, 280 (47) : 39050 - 39057